Trademarkia Logo

Canada

C$
OFEZUMIR
ADVERTISED

on 18 Sept 2024

Last Applicant/ Owned by

INCYTE HOLDINGS CORPORATION

1801 Augustine Cut-OffWilmington DE 19803

US

Serial Number

2255895 filed on 31st Mar 2023

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

OFEZUMIR

Trademark usage description

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical prep Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders.


Classification kind code

12

Class [016]
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.


Classification kind code

12

Class [044]
Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic and dermatological disorders.


Classification kind code

12

Mark Details


Serial Number

2255895

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 20th Aug 2024
Approved
Submitted for opposition 27
on 20th Aug 2024
Approval Notice Sent
Submitted for opposition 22
on 12th Aug 2024
Search Recorded
Submitted for opposition 256
on 4th Mar 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 24th May 2023
Agent Changed
Submitted for opposition 257
on 4th May 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd May 2023
Created
Submitted for opposition 31
on 3rd May 2023
Formalized
Submitted for opposition 30
on 31st Mar 2023
Filed
Submitted for opposition 228
on 31st Mar 2023
International Registration